Correlation Between HCW Biologics and Kalvista Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Kalvista Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Kalvista Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Kalvista Pharmaceuticals, you can compare the effects of market volatilities on HCW Biologics and Kalvista Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Kalvista Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Kalvista Pharmaceuticals.
Diversification Opportunities for HCW Biologics and Kalvista Pharmaceuticals
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between HCW and Kalvista is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Kalvista Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalvista Pharmaceuticals and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Kalvista Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalvista Pharmaceuticals has no effect on the direction of HCW Biologics i.e., HCW Biologics and Kalvista Pharmaceuticals go up and down completely randomly.
Pair Corralation between HCW Biologics and Kalvista Pharmaceuticals
Given the investment horizon of 90 days HCW Biologics is expected to generate 16.48 times more return on investment than Kalvista Pharmaceuticals. However, HCW Biologics is 16.48 times more volatile than Kalvista Pharmaceuticals. It trades about 0.13 of its potential returns per unit of risk. Kalvista Pharmaceuticals is currently generating about -0.14 per unit of risk. If you would invest 44.00 in HCW Biologics on August 30, 2024 and sell it today you would earn a total of 6.21 from holding HCW Biologics or generate 14.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
HCW Biologics vs. Kalvista Pharmaceuticals
Performance |
| Timeline |
| HCW Biologics |
| Kalvista Pharmaceuticals |
HCW Biologics and Kalvista Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HCW Biologics and Kalvista Pharmaceuticals
The main advantage of trading using opposite HCW Biologics and Kalvista Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Kalvista Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will offset losses from the drop in Kalvista Pharmaceuticals' long position.| HCW Biologics vs. Anebulo Pharmaceuticals | HCW Biologics vs. Rezolute | HCW Biologics vs. Eliem Therapeutics | HCW Biologics vs. Molecular Partners AG |
| Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | Kalvista Pharmaceuticals vs. Kura Oncology | Kalvista Pharmaceuticals vs. Viridian Therapeutics | Kalvista Pharmaceuticals vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |